| Date | Title | Description |
| 18.04.2025 | The AI Surge: Europe's Beacon Amidst Economic Storms | In the tumultuous sea of European startups, artificial intelligence (AI) stands as a lighthouse. While other sectors struggle, AI shines brightly, attracting investment like moths to a flame. Recent data reveals a stark contrast: total tech... |
| 17.04.2025 | The AI Revolution: Transforming Tax Preparation and Venture Capital | The landscape of tax preparation is shifting. A new partnership between OpenAI and H&R Block is set to redefine how tax professionals operate. This collaboration aims to harness the power of generative AI to streamline the tax filing pr... |
| 17.04.2025 | AI keeps the lights on: European startups double down on AI as funding declines elsewhere | Despite growing concerns around declining investment levels across the European startup ecosystem, a fresh wave of data highlights one sector that continues to defy gravity—artificial intelligence.
This article draws on three recent studies... |
| 17.04.2025 | London startups bag £2.69bn in VC funding in 2025 so far | London-based startups attracted £2.69bn in venture capital (VC) in the first three months of the year, marking a robust start of the year despite a fall in deal volumes.
According to KPMG’s latest venture pulse report, while deal count drop... |
| 16.04.2025 | VC Investment Surges in Q1 2025, Driven by AI | Global VC investment surged from $118.7 billion in Q4’24 to a ten-quarter high of $126.3 billion in Q1’25, despite ongoing geopolitical conflicts and tensions, continued concerns about global trade and tariffs, and the delay of a major reop... |
| 14.04.2025 | Health Tech Leads UK VC Investment in 2025 Q1 | UK health tech and life sciences startups raised $1.8 billion in venture capital investment in Q1 2025, the sector’s second strongest quarter on record, according to new analysis from HSBC Innovation Banking UK and Dealroom.
Health was the ... |
| 14.04.2025 | UK surges ahead of France and Germany as Europe’s ‘innovation powerhouse’ | HSBC Innovation Banking, a subsidiary of Europe’s biggest lender, hailed the UK’s enterprise value in its latest innovation report.
UK innovation firms raised £3.2bn of venture capital in the first three months of the year – an eight per ce... |
| 09.04.2025 | Inside Isomorphic Labs, the secretive AI life sciences startup spun off from Google DeepMind | Isomorphic Labs was spun out of Google DeepMind, after the tech giant achieved one of the biggest biological breakthroughs in the last 50 years.
Demis Hassabis is at the helm of both Isomorphic and DeepMind, the Google division at the foref... |
| 04.04.2025 | SandboxAQ Adds $150M From Google, Nvidia And Others | 0 Shares Email Facebook Twitter LinkedIn
Alphabet spinoff SandboxAQ — an AI and quantum computing startup — added another $150 million to its Series E from the likes of Google and Nvidia.
The add-on comes less than four months after the com... |
| 04.04.2025 | March 2025's top 10 European tech deals you need to know about | According to the Tech.eu database, European tech companies secured €5.7 billion in funding in March 2025. Although the number of deals dropped by around 30 per cent compared to the same period in 2024, the total funds raised remained steady... |
| 04.04.2025 | €51.5M for material recycling, EVs outpace Tesla models and tariffs scare Europe's investors | This week we tracked more than 75 tech funding deals worth over €1.4 billion, and over 10 exits, M&A transactions, rumours, and related news stories across Europe.In addition to this week's top financials, we've also indexed the most im... |
| 31.03.2025 | Isomorphic Labs secures $600M in funding for AI drug design | Photo: Hero Images/Getty images
Drug design and development company Isomorphic Labs announced it raised $600 million in its first external funding round.
Thrive Capital led the round, with participation from GV (Google Ventures) and existin... |
| 31.03.2025 | Isomorphic Labs nets $600M in first external funding round | A UK startup spun out of Google DeepMind focusing on leveraging AI to help drug discovery has raised $600 million, marking its first external funding round.
The funding round in Isomorphic Labs was led by Open AI-backer Thrive Capital with ... |
| 31.03.2025 | Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mission to provi... | Isomorphic Labs Inc., a healthcare startup that spun out of Alphabet Inc. in 2021, today announced that it has closed a $600 million funding round.
OpenAI backer Thrive Capital led the investment. It was joined by Alphabet and GV, the searc... |
| 31.03.2025 | Alphabet-Backed Isomorphic Labs Raises $600M For AI Drug Development | 3 Shares Email Facebook Twitter LinkedIn
Google spinoff Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply artificial intelligence to the drug development process.
The new round was led by ... |
| 31.03.2025 | Isomorphic Labs Raises $600M in Funding | Isomorphic Labs, a London, UK-based AI-first drug design and development company, raised $600M in funding.
The round was led by Thrive Capital, with participation from GV, and existing investor Alphabet.
The company intends to use the funds... |
| 18.03.2025 | UPDATE -- NVIDIA, Alphabet and Google Collaborate on the Future of Agentic and Physical AI | SAN JOSE, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- GTC -- Building on their longstanding partnership, NVIDIA, Alphabet and Google today announced new initiatives to advance AI, democratize access to AI tools, speed the development of phys... |
| 11.11.2024 | Google DeepMind open-sources AlphaFold 3, ushering in a new era for drug discovery and molecular biology | Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More
Google DeepMind has unexpectedly released the source code and model weights of AlphaFold 3 for academic use, mark... |
| 23.09.2024 | Google CEO Sundar Pichai Says AI Will Advance Humanity in These 4 Key Ways Pichai said studies show that AI could boost global labor productivity by 1.4 percentage points and increase global GDP by 7 ... |
This article originally appeared on Business Insider.
Big Tech companies like Google are betting that AI technology will help them earn billions in profits, and they're funneling tons of resources toward the technology.
But this rush to ca... |
| 08.05.2024 | Google’s AlphaFold 3 AI predicts the very building blocks of life | Join us in returning to NYC on June 5th to collaborate with executive leaders in exploring comprehensive methods for auditing AI models regarding bias, performance, and ethical compliance across diverse organizations. Find out how you can a... |
| 08.05.2024 | Google Unveils AI-Powered Molecular Structure Predictor With Unprecedented Accuracy | Aldohn Domingo, Tech Times 08 May 2024, 10:05 pm
Google's new artificial intelligence model, AlphaFold 3, is the latest AI-centered medical breakthrough. It can reportedly help create new drug designs, crops, medical treatments, and genomic... |
| 08.01.2024 | AI-driven drug discovery is poised to boom in 2024 | The AI Beat | Join leaders in San Francisco on January 10 for an exclusive night of networking, insights, and conversation. Request an invite here.
AI-driven drug discovery is about to boom in 2024, if the fast and furious pace of announcements timed to ... |
| 08.01.2024 | Alphabet’s AI-driven drug discovery startup Isomorphic lands $3 billion pharma deals with Lilly and Novartis | Alphabet’s Isomorphic, an AI-driven drug discovery startup, has scored two major deals from pharmaceutical giants Eli Lilly and Novartis, ringing in at nearly $3 billion combined. These deals will notably bolster Google DeepMind’s AlphaFold... |
| 27.07.2023 | A year ago, DeepMind’s AlphaFold AI changed the shape of science — but there is more work to do | Head over to our on-demand library to view sessions from VB Transform 2023. Register Here
OpenAI’s ChatGPT may have captured the AI zeitgeist last fall, but it was DeepMind’s AlphaFold AI that shook the science world last summer.
A year ago... |
| 28.02.2023 | How an AI breakthrough from Alphabet's DeepMind 'changed scientific history' and could lead to new cures | Researchers at the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia use DeepMind's AlphaFold 2 technology to predict protein structures while researching Parkinson's disease. DeepMind This story is available exclu... |
| 05.11.2021 | Alphabet launches new company to use AI for drug research | Team TC 5 Nov, 2021
Google's parent company Alphabet has created a new company called Isomorphic Labs to leverage artificial intelligence (AI) for medical research and drug discovery.
Alphabet's AI company DeepMind has already made some inr... |
| 05.11.2021 | A pair of European biotechs hit below their mark as close of 2021 biotech IPO market chugs a little bit slower | Say hello to yet two more biotechs that jumped on a 2021 IPO this week.
German firm Evotec SE debuted a downsized IPO in the US yesterday — pricing at $21.75 per ADS share and $43.50 for a share on Nasdaq under the ticker $EVO.
Th... |
| 05.11.2021 | San Fran biotech gets another blow to lead drug; Swiss biotech raises $49 million in Series A — with help from big venture | In the wake of Calithera Biosciences axing a third of its workforce in January over a failed Phase II trial with lead drug telaglenastat in patients with renal cell carcinoma, they just got slammed with the second half of a ... |
| 05.11.2021 | Google’s Alphabet jumps into the drug business with the launch of Isomorphic Labs, an AI-driven drug discovery startup | The global pharmaceutical manufacturing market size was valued at $405.52 billion in 2020 and is expected to grow at a compound annual growth rate of 11.34% from 2021 to 2028. Thanks to covid vaccines, pharmaceutical companies like Pfizer, ... |
| 05.11.2021 | Cell therapy startup bit.bio adds $100M+ to its coffers and some impressive names to its board of directors | Bit.bio CEO Mark Kotter says the last major revolution in biopharma occurred around the 1980s, when antibodies — or, as some called them, anticancer “magic bullets” — opened up the door for new therapies.
Now cell therapy... |
| 05.11.2021 | Pierre Beaurang hits the ground running at his 3rd startup; Mike Grey poaches Astellas dealmaker to head protein degradation player | Pierre Beaurang
As Nitrome Biosciences — a biotech founded in 2017 to focus on a class of enzymes called nitrases — rebrands to Nitrase Therapeutics, the company is also bringing on a new CEO: Pierre Beaurang.
In Nitrase’s... |
| 05.11.2021 | Covid-19 roundup: Novavax's manufacturing woes nearing an end?; FDA rejects coronavirus drug in NIH trial | The US government’s $1.8 billion investment into Novavax’s Covid-19 vaccine may soon pay off as the company floated some positive comments around the issues surrounding the manufacturing of its recombinant protein v... |
| 04.11.2021 | FDA adcomm votes 12-1 against Levo Therapeutics' nasal spray for a disorder that causes insatiable hunger | The FDA’s Psychopharmacologic Drugs Advisory Committee on Thursday voted 12 to 1 against approving Levo Therapeutics’ nasal spray for Prader-Willi syndrome, a difficult-to-treat disease that leaves patients with con... |
| 04.11.2021 | Alphabet kickstarts new AI drug discovery outfit with lessons learned from DeepMind protein breakthroughs | Last summer marked a major breakthrough in drug discovery when DeepMind, a predictive modeling startup from Google parent company Alphabet, offered the most accurate picture yet of the “protein folding” problem. The A... |
| 04.11.2021 | Isomorphic Labs is Alphabet’s play in AI drug discovery | The field of drug discovery has been supercharged by the capabilities of AI, which several companies have applied in various ways to turn an enormous practical problem into a tractable information problem. The latest to do so is Google pare... |
| 04.11.2021 | Alphabet kickstarts new AI drug discovery outfit with lessons learned from DeepMind protein breakthroughs | Moderna has drawn plaudits from around the industry and the globe for its Covid-19 vaccine, and it reported continued financial success Thursday in its third-quarter report. But the biotech also quietly announced the discontinuation of anot... |
| 04.11.2021 | More than a year after trimming R&D unit, Ironwood adds a rare disease drug to the pipeline in hopeful step forward | Ironwood Pharmaceuticals has walked a less-than-easy path the past few years with a proxy-driven shakeup and multiple clinical failures rocking the company. Now under new leadership, Ironwood is snagging rights to a rare... |
| 04.11.2021 | PlateletBio announces $75.5M Series B to extend autoimmune cell therapy | More than two years after PlateletBio landed its first round of fundraising and a contract with the US government, the company announced its Series B round Thursday.
The preclinical stage biotech out of Watertown, MA annou... |
| 04.11.2021 | GenScript drops a modest investment into its supply capacity as business booms | Ray Miller
New Jersey’s GenScript announced the opening of a 50,000-square-foot facility for automated gene synthesis and plasmid production services near its Piscataway headquarters Tuesday. The expansion will ensur... |
| 04.11.2021 | Lonza enters the exosome therapy space with acquisition of still-new Codiak site | In anticipation of tackling the manufacturing problems that come with exosome therapeutics head on, Codiak BioSciences built a 12,000-square-foot manufacturing site in Lexington, MA. Tuesday, it announced that it w... |
| 04.11.2021 | Touting close ties to biotech incubators, Mission BioCapital grabs $275M to help launch startups | Before moving to shiny new offices on their venture dimes, many biotech startups trace their beginnings back to shared laboratory spaces like LabCentral and BioLabs.
As the influx of VC dollars push more seasoned players ... |
| 04.11.2021 | Bluebird bio completes split into two companies; BeiGene builds out Brukinsa data at ASH | Bluebird bio has been officially split in half.
Both sides of the once-singular cell and gene therapy company announced Thursday they have completed their split into two biotechs: A gene therapy-focused outfit that will r... |
| 04.11.2021 | Hiccup in manufacturing will cause GenSight to repeat the process for retinal gene therapy; Dendreon announces collaboration with Shoreline Biosciences | Four months after a gene therapy Phase III trial for retinal neurodegenerative diseases from French biotech GenSight failed despite improvement in vision in patients, the company has announced that it has completed thr... |
| 04.11.2021 | Alphabet kickstarts new AI drug discovery outfit with lessons learned from DeepMind protein breakthroughs | Recouping from a series of setbacks for its gene therapy business, bluebird bio successfully bisected itself earlier this week as part of a big rebrand around genetic disease. Now, with its future still in the wind, bluebird has found a new... |
| 04.11.2021 | Alphabet kickstarts new AI drug discovery outfit with lessons learned from DeepMind protein breakthroughs | Moderna’s stock $MRNA plunged more than 14% in premarket trading on Thursday after the biotech cut its end-of-year vaccine sales forecast.
According to its Q3 results, Moderna now plans on delivering between 700 million and 800 million dose... |
| 04.11.2021 | Alphabet kickstarts new AI drug discovery outfit with lessons learned from DeepMind protein breakthroughs | Another senior leader at the FDA has moved on, and this time it’s FDA’s chief scientist Denise Hinton, a nearly 20-year agency veteran who has now moved over to serve as deputy surgeon general.
Rear Admiral Hinton, who first joined FDA in 2... |
| 11.08.2021 | Стартап Alphabet займется созданием новых лекарств | Alphabet, материнская компания Google, объявила о создании стартапа Isomorphic Labs. Он займется разработкой новых лекарств с помощью технологий искусственного интеллекта.
Isomorphic Labs зарегистрировали в Великобритании. Стартап возглавит... |
| - | Meet the DeepMind mafia: These 18 alumni from Google's AI research lab are raising millions for their own startups, from climate to crypto | Andrew Eland, Adji Bousso Dieng, and Tiago Ramalho. Andrew Eland; Adji Bousso Dieng; and Tiago Ramalho; Shayanne Gal/Insider This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
DeepMind is Go... |
| - | Alphabet запустила новую AI-компанию | Александра Кукуть 5 ноября 2021, 10:15 2021-11-05 Alphabet запустила новую AI-компанию
Alphabet — материнская компания Google — создала новую компанию под названием Isomorphic Laboratories. Она займётся поиском формул лекарств посредством и... |
| - | Schrödinger: инвестиции в drug discovery и materials science. Есть ли перспективы после падения акций на 70%? | Для инвесторов в биотех и фармацевтические компании последний год выдался непростым. Популярный ETF SPDR S&P Biotech, он же XBI, состоящий в основном из биотехов малой и средней капитализации, потерял уже более 40% с пиковых значений в ... |
| - | Isomorphic Labs | “Isomorphic Labs is building a future where frontier AI can help to unlock deeper scientific insights, faster breakthroughs, and life-changing medicines.” |
| - | How to impress recruiters at DeepMind, the futuristic Google research unit creating AI programs that rival humans | DeepMind's lead AlphaGo researcher David Silver (left) and DeepMind CEO Demis Hassabis (right). DeepMind This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Redeem now
DeepMind is Google's Lo... |
| - | Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business | Isomorphic Labs, Google’s artificial intelligence drug business, raised $600 million in its first external funding round, the company said on Monday.
Thrive Capital, a venture capital firm, led the funding round with participation from Goog... |
